SE9601528D0 - Transdermally administered dextromethorphan as antitissue agent - Google Patents
Transdermally administered dextromethorphan as antitissue agentInfo
- Publication number
- SE9601528D0 SE9601528D0 SE9601528A SE9601528A SE9601528D0 SE 9601528 D0 SE9601528 D0 SE 9601528D0 SE 9601528 A SE9601528 A SE 9601528A SE 9601528 A SE9601528 A SE 9601528A SE 9601528 D0 SE9601528 D0 SE 9601528D0
- Authority
- SE
- Sweden
- Prior art keywords
- antitissue
- agent
- transdermally administered
- dextromethorphan
- administered dextromethorphan
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Priority Applications (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9601528A SE9601528D0 (sv) | 1996-04-23 | 1996-04-23 | Transdermally administered dextromethorphan as antitissue agent |
AU23132/97A AU714942B2 (en) | 1996-04-23 | 1997-03-21 | Transdermally administered dextromethorphan as antitussive agent |
PT97915801T PT904067E (pt) | 1996-04-23 | 1997-03-21 | Dextrometorfan como agente antitussico administrado transdermicamente |
EP97915801A EP0904067B1 (de) | 1996-04-23 | 1997-03-21 | Transdermal verabreichtes dextromethorphan als hustenmittel |
AT97915801T ATE284206T1 (de) | 1996-04-23 | 1997-03-21 | Transdermal verabreichtes dextromethorphan als hustenmittel |
ES97915801T ES2234012T3 (es) | 1996-04-23 | 1997-03-21 | Dextrometorfano administrado transdermicaente como agente antitusivo. |
NZ332215A NZ332215A (en) | 1996-04-23 | 1997-03-21 | Transdermally administered dextromethorphan as antitussive agent |
PCT/SE1997/000484 WO1997039742A1 (en) | 1996-04-23 | 1997-03-21 | Transdermally administered dextromethorphan as antitussive agent |
CA002251966A CA2251966C (en) | 1996-04-23 | 1997-03-21 | Transdermally administered dextromethorphan as antitussive agent |
US09/171,674 US6335030B1 (en) | 1996-04-23 | 1997-03-21 | Transdermally administered dextromethorphan as antitussive agent |
DK97915801T DK0904067T3 (da) | 1996-04-23 | 1997-03-21 | Transdermalt indgivet dextromethorpan som hostestillende middel |
JP9537974A JP2000509037A (ja) | 1996-04-23 | 1997-03-21 | 鎮咳剤として経皮投与されるデキストロメトルファン |
DE69731882T DE69731882T2 (de) | 1996-04-23 | 1997-03-21 | Transdermal verabreichtes dextromethorphan als hustenmittel |
ZA9703444A ZA973444B (en) | 1996-04-23 | 1997-04-22 | Transdermally administered dextromethorphan as antitussive agents. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9601528A SE9601528D0 (sv) | 1996-04-23 | 1996-04-23 | Transdermally administered dextromethorphan as antitissue agent |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9601528D0 true SE9601528D0 (sv) | 1996-04-23 |
Family
ID=20402295
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9601528A SE9601528D0 (sv) | 1996-04-23 | 1996-04-23 | Transdermally administered dextromethorphan as antitissue agent |
Country Status (14)
Country | Link |
---|---|
US (1) | US6335030B1 (de) |
EP (1) | EP0904067B1 (de) |
JP (1) | JP2000509037A (de) |
AT (1) | ATE284206T1 (de) |
AU (1) | AU714942B2 (de) |
CA (1) | CA2251966C (de) |
DE (1) | DE69731882T2 (de) |
DK (1) | DK0904067T3 (de) |
ES (1) | ES2234012T3 (de) |
NZ (1) | NZ332215A (de) |
PT (1) | PT904067E (de) |
SE (1) | SE9601528D0 (de) |
WO (1) | WO1997039742A1 (de) |
ZA (1) | ZA973444B (de) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6846495B2 (en) * | 1999-01-11 | 2005-01-25 | The Procter & Gamble Company | Compositions having improved delivery of actives |
DE19901085C2 (de) * | 1999-01-14 | 2003-12-18 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit einer selbstklebenden Matrix, enthaltend organische Säure-Additionssalze von Alkaloiden des Morphin- bzw. Morphinantyps |
GB9920167D0 (en) * | 1999-08-25 | 1999-10-27 | Avery Dennison Corp | Pressure sensitive adhesive compositions |
US7138133B2 (en) | 2001-10-10 | 2006-11-21 | The Procter & Gamble Company | Orally administered liquid compositions |
US8133505B2 (en) * | 2002-10-31 | 2012-03-13 | Transpharma Medical Ltd. | Transdermal delivery system for dried particulate or lyophilized medications |
IL152574A (en) * | 2002-10-31 | 2009-09-22 | Transpharma Medical Ltd | A system for passing through the skin of dry items or dried medicines |
US7662404B2 (en) * | 2002-10-31 | 2010-02-16 | Transpharma Medical Ltd. | Transdermal delivery system for dried particulate or lyophilized peptides and polypeptides |
US7383084B2 (en) * | 2002-10-31 | 2008-06-03 | Transpharma Medical Ltd. | Transdermal delivery system for dried particulate or lyophilized medications |
US8502681B2 (en) * | 2005-06-20 | 2013-08-06 | Biovigil, Llc | Hand cleanliness |
JP5015620B2 (ja) * | 2007-01-30 | 2012-08-29 | 株式会社クラレ | 皮膚外用剤 |
US20100160368A1 (en) * | 2008-08-18 | 2010-06-24 | Gregory Jefferson J | Methods of Treating Dermatological Disorders and Inducing Interferon Biosynthesis With Shorter Durations of Imiquimod Therapy |
EA201100984A1 (ru) | 2008-12-19 | 2012-01-30 | Грэйсуэй Фармасьютикалс, Ллс | Композиции с более низким содержанием имиквимода и короткие режимы дозирования для лечения актинического кератоза |
EP2453747B1 (de) | 2009-07-13 | 2017-08-30 | Medicis Pharmaceutical Corporation | Imiquimod-formulierungen mit geringerer dosisstärke und kurze dosierpläne zur behandlung von warzen im genital- und perianalbereich |
US8461102B2 (en) * | 2010-03-02 | 2013-06-11 | George E. Royster, JR. | Methods and compositions for treating and preventing symptoms of hormonal variations |
US10493049B2 (en) | 2016-02-10 | 2019-12-03 | Niracle LLC | Applicator-based transdermal drug delivery system for administration of drugs in combination with topical formulations |
TWI795446B (zh) * | 2017-10-04 | 2023-03-11 | 美商神經治療股份有限公司 | 右旋美索芬(dextromethorphan)經皮輸送裝置 |
EP4125902A4 (de) * | 2020-03-30 | 2024-05-22 | Shinkei Therapeutics, Inc. | Transdermale verabreichung von dextromethorphan |
CN117545474A (zh) | 2021-11-08 | 2024-02-09 | 李维庸 | 一种用于向患者递送药物的透皮给药系统 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3275510A (en) * | 1966-09-27 | Topical antitussive preparations | ||
US2676177A (en) | 1949-11-09 | 1954-04-20 | Hoffmann La Roche | Process for the preparation of optically active 3-methoxy-n-methyl morphinans and salts thereof |
US4557934A (en) | 1983-06-21 | 1985-12-10 | The Procter & Gamble Company | Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one |
US4645502A (en) * | 1985-05-03 | 1987-02-24 | Alza Corporation | Transdermal delivery of highly ionized fat insoluble drugs |
JPS6351327A (ja) * | 1986-08-22 | 1988-03-04 | Sato Seiyaku Kk | 液状組成物 |
US4783450A (en) | 1987-04-13 | 1988-11-08 | Warner-Lambert Company | Use of commercial lecithin as skin penetration enhancer |
US4888354A (en) | 1987-12-21 | 1989-12-19 | Theratech, Inc. | Skin penetration enhancement using free base and acid addition salt combinations of active agents |
US4915950A (en) | 1988-02-12 | 1990-04-10 | Cygnus Research Corporation | Printed transdermal drug delivery device |
US5164406A (en) | 1988-06-02 | 1992-11-17 | Bristol-Myers Squibb Co. | Method for enhancing transdermal penetration and compositions useful therein |
EP0351897A3 (de) | 1988-06-17 | 1990-03-21 | The Procter & Gamble Company | Hautpenetrierendes System für aminfunktionelle Anrzneistoffsalze |
WO1991015261A1 (en) * | 1990-03-30 | 1991-10-17 | Medtronic, Inc. | Activity controlled electrotransport drug delivery device |
US5213568A (en) | 1990-03-30 | 1993-05-25 | Medtronic Inc. | Activity controlled electrotransport drug delivery device |
PL168968B1 (en) | 1990-10-31 | 1996-05-31 | Procter & Gamble | Method of manufacturing an antitussive drug |
GB9103302D0 (en) * | 1991-02-16 | 1991-04-03 | Smithkline Beecham Plc | Pharmaceutical formulations |
EP0608320B1 (de) | 1991-10-16 | 1998-01-28 | Richardson-Vicks, Inc. | Verbesserte hautpenetrationssysteme fuer erhoehte topische freisetzung von arzneimitteln |
EG20380A (en) | 1991-10-16 | 1999-02-28 | Richardson Vicks Inc | Enhanced skin penetration system for improved topical delivery of drugs |
US5260066A (en) | 1992-01-16 | 1993-11-09 | Srchem Incorporated | Cryogel bandage containing therapeutic agent |
US5756117A (en) * | 1992-04-08 | 1998-05-26 | International Medical Asscociates, Inc. | Multidose transdermal drug delivery system |
CA2169729C (en) | 1993-08-19 | 2001-04-03 | James E. Biegajski | Water-soluble pressure-sensitive mucoadhesive |
-
1996
- 1996-04-23 SE SE9601528A patent/SE9601528D0/xx unknown
-
1997
- 1997-03-21 WO PCT/SE1997/000484 patent/WO1997039742A1/en active IP Right Grant
- 1997-03-21 DE DE69731882T patent/DE69731882T2/de not_active Expired - Fee Related
- 1997-03-21 EP EP97915801A patent/EP0904067B1/de not_active Expired - Lifetime
- 1997-03-21 DK DK97915801T patent/DK0904067T3/da active
- 1997-03-21 NZ NZ332215A patent/NZ332215A/xx unknown
- 1997-03-21 PT PT97915801T patent/PT904067E/pt unknown
- 1997-03-21 CA CA002251966A patent/CA2251966C/en not_active Expired - Fee Related
- 1997-03-21 AU AU23132/97A patent/AU714942B2/en not_active Ceased
- 1997-03-21 JP JP9537974A patent/JP2000509037A/ja active Pending
- 1997-03-21 AT AT97915801T patent/ATE284206T1/de not_active IP Right Cessation
- 1997-03-21 ES ES97915801T patent/ES2234012T3/es not_active Expired - Lifetime
- 1997-03-21 US US09/171,674 patent/US6335030B1/en not_active Expired - Lifetime
- 1997-04-22 ZA ZA9703444A patent/ZA973444B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
EP0904067B1 (de) | 2004-12-08 |
DE69731882D1 (de) | 2005-01-13 |
US6335030B1 (en) | 2002-01-01 |
NZ332215A (en) | 2000-09-29 |
DE69731882T2 (de) | 2005-12-15 |
AU2313297A (en) | 1997-11-12 |
PT904067E (pt) | 2005-02-28 |
ZA973444B (en) | 1997-11-18 |
CA2251966A1 (en) | 1997-10-30 |
ES2234012T3 (es) | 2005-06-16 |
AU714942B2 (en) | 2000-01-13 |
JP2000509037A (ja) | 2000-07-18 |
CA2251966C (en) | 2008-01-15 |
DK0904067T3 (da) | 2005-03-14 |
WO1997039742A1 (en) | 1997-10-30 |
EP0904067A1 (de) | 1999-03-31 |
ATE284206T1 (de) | 2004-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE9601528D0 (sv) | Transdermally administered dextromethorphan as antitissue agent | |
NZ508526A (en) | Opioid formulations for treating pain | |
NO931766D0 (no) | Topiske preparater for transdermal avlevering av forloeperlegemiddelderivater av morfin | |
CA2341063A1 (en) | Transdermally administered tolterodine as anti-muscarinic agent for the treatment of overactive bladder | |
GR3032523T3 (en) | Therapeutic preparation for the transdermal administration of active substances | |
ES2137261T3 (es) | Administracion transdermica de oxibutinina. | |
WO2001013909A3 (en) | Compositions and methods for treating opiate intolerance | |
TR199801180T2 (xx) | Aneljestik etkiye sahip yeni bile�ikler. | |
NO993385D0 (no) | Transdermalt terapeutisk system for avgivelse av hormoner | |
YU49026B (sh) | UPOTREBA 17 Гџ -(N-TERC-BUTILKARBAMOIL)-4-AZA-5-ALFA-ANDROST-1-3-ON ZA PROIZVODNJU LEKA ZA TRETIRANJE ANDROGENE ALOPECIJE | |
TR200103613T2 (tr) | Burun içinden tatbik edilen morfini içeren farmasötik formülasyonlar ve yöntemler. | |
DK0538302T3 (da) | Reduktion eller forhindring af hudirritation forårsaget af lægemidler | |
DK0754034T3 (da) | Brusende farmaceutiske formuleringer indeholdende biologisk nedbrydelige mikrokapsler med kontrolleret afgivelse | |
PT1003477E (pt) | Sistema terapeutico transdermico (tts), contendo polimeros de (met)acrilato com grupos amonio para administracao de levonorgestrel | |
ATE388687T1 (de) | Medikamentöse verabreichung von nikotin in form von kaugummi | |
HK1038310A1 (en) | Compositions and methods for treating intracellular infections. | |
MY124465A (en) | Reduction of infarct volume using citicoline | |
SE9601527D0 (sv) | Transdermally alministered acetylcysteine as mucolytic agent | |
MY126321A (en) | Use of (alpha)-adrenoreceptor antagonists in the prevention and treatment of cancer. | |
ATE81775T1 (de) | Pharmazeutische zusammensetzungen. | |
ATE280575T1 (de) | Transdermales therapeutisches system zur anwendung von candesartan | |
GR900100489A (el) | Συνθέσεις χρήσιμοι ως αντισυλληπτικά για άνδρες. | |
EP0906757A3 (de) | Analgetische Zusammensetzung welche Moxonidine und ein Opioid-Analgetika enthält | |
DK408188D0 (da) | Injicerbart middel til kontrolleret frigivelse af opioid-analgetika | |
MX9604426A (es) | Reduccion de irritacion de la piel durante el surtido por electrotransporte. |